Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
API 31510 Topical Cream for In Situ Cutaneous Squamous Cell Carcinoma
NCT00605709Phase 2Withdrawn
- Sponsor
- BPGbio
- Start
- Mar 2008
- Primary completion
- Jul 2008
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of ubidecarenone nanodispersion in cutaneous squamous cell carcinoma (cSCC), sponsored by BPGbio. Planned start Mar 2008; status: withdrawn.
02
Drugs
ubidecarenone nanodispersion
03
Conditions
cutaneous squamous cell carcinoma (cSCC)
Beyond the preview
Go deeper on NCT00605709.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00605709.